Titration schedule planner
GLP-1 Titration Schedule Planner
Turns a start date into the actual weeks of your dose ladder, taking every step and its duration from the drug's own FDA prescribing information. Pick the medication, set the date, and say where you are now if you want only what is left rather than the whole climb.
Important: How you tolerate it is what your prescriber will adjust against. What you see is the label's standard protocol, and no dose on it moves without clinical guidance. Where a step is genuinely intolerable, speak to them before the next increase rather than after it.
Wegovy (semaglutide 2.4 mg) — titration calendar
| Week | Date range | Dose | Pen color | Notes |
|---|---|---|---|---|
| Week1 | Dates— | Dose0.25 mg weekly | Pen colorLight blue | Starting dose — dose-escalation phase |
| Week2 | Dates— | Dose0.25 mg weekly | Pen colorLight blue | Starting dose — dose-escalation phase |
| Week3 | Dates— | Dose0.25 mg weekly | Pen colorLight blue | Starting dose — dose-escalation phase |
| Week4 | Dates— | Dose0.25 mg weekly | Pen colorLight blue | Starting dose — dose-escalation phase |
| Week5 | Dates— | Dose0.5 mg weekly | Pen colorRed-violet | |
| Week6 | Dates— | Dose0.5 mg weekly | Pen colorRed-violet | |
| Week7 | Dates— | Dose0.5 mg weekly | Pen colorRed-violet | |
| Week8 | Dates— | Dose0.5 mg weekly | Pen colorRed-violet | |
| Week9 | Dates— | Dose1 mg weekly | Pen colorYellow | |
| Week10 | Dates— | Dose1 mg weekly | Pen colorYellow | |
| Week11 | Dates— | Dose1 mg weekly | Pen colorYellow | |
| Week12 | Dates— | Dose1 mg weekly | Pen colorYellow | |
| Week13 | Dates— | Dose1.7 mg weekly | Pen colorTeal | |
| Week14 | Dates— | Dose1.7 mg weekly | Pen colorTeal | |
| Week15 | Dates— | Dose1.7 mg weekly | Pen colorTeal | |
| Week16 | Dates— | Dose1.7 mg weekly | Pen colorTeal | |
| Week17 | Dates— | Dose2.4 mg weekly | Pen colorDark blue | MAINTENANCEMaintenance dose reached |
| Week18 | Dates— | Dose2.4 mg weekly | Pen colorDark blue | MAINTENANCEMaintenance dose reached |
| Week19 | Dates— | Dose2.4 mg weekly | Pen colorDark blue | MAINTENANCEMaintenance dose reached |
| Week20 | Dates— | Dose2.4 mg weekly | Pen colorDark blue | MAINTENANCEMaintenance dose reached |
How the planner works
Nothing here is invented. Every dose, every duration, every pen color is read off the prescribing information for that drug, and all this does is lay the label's own protocol against real dates.
- Wegovy (semaglutide) [1]: Four-week steps, five of them, carrying 0.25 mg up to a maintenance dose of 2.4 mg across 16 weeks.
- Ozempic (semaglutide) [2]: Four weeks at 0.25 mg to begin, then 0.5 mg, with 1.0 mg and 2.0 mg available above that if needed.
- Zepbound / Mounjaro (tirzepatide) [3][4]: Sixteen weeks, rising 2.5 mg at a time every four, from 2.5 mg to a ceiling of 15 mg.
- Foundayo (orforglipron) [5]: A tablet taken daily, climbing from 3 mg to a maintenance dose of 36 mg over 12 weeks.
Important warning
How you tolerate it is what your prescriber will adjust against. What you see is the label's standard protocol, and no dose on it should move without clinical guidance. Where a rung is genuinely intolerable, speak to your prescriber before your next scheduled increase — they may recommend staying at the current dose for additional weeks or reducing the dose.
What this planner does NOT do
- It gives no medical advice and replaces no conversation with your prescriber.
- It cannot judge how you are coping. Every label carries “as tolerated” language, and applying that is your prescriber's job rather than this page's.
- It writes no prescription and places no order.
- It records nothing you actually did. What you see is the plan, for reference.
Important disclaimer
Educational only. Neither medical advice nor a prescription. What it lays out is the standard protocol from each label, and yours may well run differently once your clinical response, your tolerance and your prescriber's judgment are in play. No dose changes without talking to them first.
References
- 1.Novo Nordisk. Wegovy (semaglutide) injection, for subcutaneous use — Prescribing Information. Section 2.1: Recommended Dosage. FDA / Drugs@FDA. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215256s007lbl.pdf
- 2.Novo Nordisk. Ozempic (semaglutide) injection, for subcutaneous use — Prescribing Information. Section 2.1. FDA / Drugs@FDA. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/209637s020lbl.pdf
- 3.Eli Lilly and Company. Zepbound (tirzepatide) injection, for subcutaneous use — Prescribing Information. Section 2.1. FDA / Drugs@FDA. 2023. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215866s000lbl.pdf
- 4.Eli Lilly and Company. Mounjaro (tirzepatide) injection, for subcutaneous use — Prescribing Information. Section 2.1. FDA / Drugs@FDA. 2022. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215866Orig1s000lbl.pdf
- 5.Eli Lilly and Company. Foundayo (orforglipron) tablets — Prescribing Information. FDA / Drugs@FDA. 2025. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218226s000lbl.pdf
Related tools and research
- GLP-1 Dose Plotter — visualize your dose history over time
- GLP-1 Unit Converter — convert between mg, mL, and units
- GLP-1 Missed Dose Guide — a dose missed partway up the ladder
- GLP-1 Weight Loss Calculator — week-by-week weight loss projections
- Switching between GLP-1 medications — what changing drug does to the ladder
- Semaglutide side effects: what to expect — the gut effects that set how fast you can climb
- Side-effect timeline tool — when each side effect peaks and resolves, by drug and week. Slower titration shifts the peak; this tool shows what you avoid.
How far people get up the ladder in practice is covered in many people never reach the dose.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Gala
Moving between compounded and brand without changing seller
From $179/mo
Get started →Sesame Care
Oral orforglipron alongside the injectables
From $149/mo + care fee
Get started →Oak
A choice of compounded injections, oral semaglutide and brand-name GLP-1s from one cash-pay checkout
From $100/mo
Get started →